September 1, 2021 Cancer/testis antigen expression landscape in gastroesophageal adenocarcinoma Read more »
September 30, 2021 Aligning Tumor Mutational Burden (TMB) quantification across diagnostic platforms: Phase 2 of the Friends of Cancer Research TMB Harmonization Project Read more »
November 1, 2021 Molecular profiling of metastatic renal cell carcinoma treated with ipilimumab-nivolumab Read more »
April 2, 2022 Cancer testis antigen burden: pan-cancer distribution and survival implications Read more »
March 4, 2021 T-cell CX3CR1 expression as a dynamic blood-based biomarker of response to immune checkpoint inhibitors Read more »
April 16, 2021 Cross-oncopanel study reveals high sensitivity and accuracy with overall analytical performance depending on genomic regions Read more »
July 1, 2022 LAG3 transcriptomic expression correlates with high levels of PD-1, PD-L1, PD-L2, and CTLA-4 checkpoints and with high tumor mutational burden across cancers Read more »
December 2, 2021 A scalable high-throughput targeted next-generation sequencing assay for comprehensive genomic profiling of solid tumors Read more »
October 18, 2022 Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor response in metastatic renal cell carcinoma Read more »